Cite
MLA Citation
Thor Ostenfeld et al.. “[O2–09–02]: EVALUATION OF SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF MEDI1814, A BETA‐AMYLOID 42 (Aβ42)‐SPECIFIC ANTIBODY, IN PATIENTS WITH MILD‐MODERATE ALZHEIMER'S DISEASE.” Alzheimer's & dementia, vol. 13, n.d., p. P574. http://access.bl.uk/ark:/81055/vdc_100103092152.0x00001f